INTERNATIONAL PATENT: CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD., 石药集团巨石生物制药有限公司 FILES APPLICATION FOR "USE OF COMBINATION OF ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND IMMUNE CHECKPOINT INHIBITOR"

GENEVA, Jan. 12 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. (519, Cangsheng Road, High-Tech Development ZoneShijiazhuang, Hebei 050027), 石药集团巨石生物制药有限公司 (中国河北省石家庄市高新区仓盛路519号) filed a patent application (PCT/CN2025/107006) for "USE OF COMBINATION OF ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND IMMUNE CHECKPOINT INHIBITOR" on Jul 04, 2025. With publication no. WO/2026/008043, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classi...